Abstract: To elucidate the effect of local bFGF administration, we administered a total of 0.3μg rhbFGF was to the left mandibular condyle by three injections of 0.1μl bFGF solution for 3 days after birth. The contralateral condyles with three injections of 0.1μl physiologic saline served as controls. Serial sections including the widest condyle were evaluated with H-E staining and immunostaining for PCNA. The maximum width of condyle, proliferative zone thickness, proliferative zone thickness ratio and proliferating index were analyzed using image analysis software after digital image capture of H-E stained sections. All condyles were composed of fibrous, proliferative, maturation and hypertrophic cell zones without significant abnormal findings. Experimental condyles demonstrated a markedly thickened proliferative zone compared with that of the controls at 1 day after the injection. At 4 and 7 days, chondrocytes and hypertrophic chondrocytes of the experiments increased in thickness. However, at 14 days after the injection, both the controls and experiments showed similar features with an upward shift of ossification front and active formation of bone trabeculae. Morphometrically, all values of experiments were significantly higher than those of the controls. Especially at 4 days after the final injection, proliferative zone thickness and proliferative index values of the experiment reached a peak and were nearly 1.6-fold higher than those of the control, which were statistically significant compared to other experimental groups. Despite the short half-life of rhbFGF, its effect seems to be prolonged by synergic actions of growth factors such as bFGF or TGF beta1. In conclusion, we showed that local administration of bFGF was feasible for accelerating mesenchymal cell proliferation of mandibular condyles of newborn mice in the lactation period after birth.
Introduction
Fibroblast growth factor (FGF) is a growth factor that was first purified as a polypeptide of 13,300 molecular weight from bovine pituitary gland in 1970s 1) . FGF isolated under non-acidic conditions was referred to as basic pituitary FGF possessing mitogenic activity 2) . However, FGFs are now recognized as proteins that bind to FGFRs and induce the phosphorylation 3, 4) .
This family, binding heparin and heparan sulfate, regulates articular cartilage homeostasis and controls the growth, differentiation, migration and survival of a wide variety of cell types. In this family, basic fibroblast growth factor (bFGF) also known as FGF-2 regulates mesenchymal cell proliferation but not epithelial cell 5) . This regulator plays an important role in cartilage matrix homeostasis 6) and bone growth and development 7) . In mandibular condyle, bFGF modulates cartilage proliferation not only in normal condylar cartilage cells 8) but also in neoplastic cartilage cells such as in synovial chondromatosis 9) . In addition, this factor seems to be physiologically involved in the alteration of the mandibular condylar cartilage due to lateral movement of the mandible 10) . Clinically, bFGF has been applied to various diseases. For example, it is effective in wound healing and has been applied in cases of plastic surgery 11) . There has been considerable research on the treatment of articular disorders. Although the trial of bFGF injection into rat knee joints had been reported by Shida and his coworkers 12) bFGF injection into mandibular condyles. Our goal of current study is to elucidate the effect of local bFGF administration on newborn mouse condyles.
Materials and Methods

Animal and experimental preparations
Forty newborn ddY mice (Japan SLC Inc. Hamamatsu, Japan) were divided into four groups (10 /group). Mice weighed approximately 1 g at birth and 6 g or more at 2-weeks of age. Prior to experiments, we prepared handmade micro-syringes that enabled us to eject 0.1 μl solution per one drop using a NanoPass ® tapered 33 gauge needle (Terumo, Tokyo, Japan). To confirm the position of the needle tips and distribution of injected solution, 3D micro-CT (R mCT, Rigak, Tokyo, Japan) images were taken before and after subcutaneous injection of contrast medium (Iopamiron ® Inj., Bayer Yakuhin, Ltd., Tokyo, Japan).
Experimental design
Ten μg of recombinant human basic fibroblast growth factor (rhbFGF, PROGEN Biotechnik GmbH, Heidelberg, Germany was reconstituted in 10 μl distilled water. Final concentration of bFGF solution was 1 μg/μl. As shown in Fig. 1 , total 0.3 μg of rhbFGF was administered to the left mandibular condyle by three injections of 0.1 μl bFGF solution for 3 days after birth. The contralateral, right condyle received three injections of 0.1 μl physiologic saline. The left and right mandibular condyles served as experiments and controls, respectively. The new bone mice were kept in an air-conditioned room with controlled temperature at 24±1ºC and fed with their mother, freely taking solid feed (Japan SLC Inc. Hamamatsu, Japan) and water. The ethics committee on laboratory animals of Matsumoto Dental University approved this study.
Preparation and selection of histological sections
Ten mice of each control and experimental group were euthanized at 1, 4, 7 and 14 days after the final injection. Resected specimens were routinely treated after fixation in 4% paraformaldehyde in 0.05 M phosphate buffer for 24 hours and decalcification in 10% EDTA for 3 weeks. Three micron-thick, serial frontal sections through both condyles were made from paraffin blocks. About 800 sections including both condyles were obtained from each sample. In order to select the section that contained the widest frontal section of the condyle, one out of every 20 sections was stained with hematoxylin and eosin (H-E) and the condyle widths of both sides were measured using a microscope system (Olympus BX61
with digital camera DP71, Olympus Corporation, Tokyo, Japan) and Motic Image Plus 2.1 version 2.1.2 (Shimazu, Tokyo, Japan).
Finally, we used a set of 20 serial sections including the widest section for immunohistochemical staining.
Immunohistochemistry
After high-temperature unmasking technique was performed by an autoclave at 121°C for 15 minutes in 0.01 M sodium citrate buffer solution (pH6.0), three micron-thick paraffin sections were routinely treated. Anti-proliferation cell nuclear antigen (PCNA) antibody (Dako, Glostrup, Denmark) as primary antibodies and Nichirei MAX-PO Multi (Nichirei, Tokyo, Japan) as a secondary antibody were incubated 4 overnight and at room temperature 30 minutes, respectively. After visualization with 3-3'-diaminobenzidine tetrahydrochloride (Dako, Glostrup, Denmark), sections were counterstained with hematoxylin. Negative control slides were processed without the primary antibodies.
Image analyses
All digital images (JPEG, 1600×1200 pixels) of H-E staining sections were captured with a 10× objective lens using a microscope system (Olympus BX61 with digital camera DP71, Olympus Corporation, Tokyo, Japan). As is shown in Fig. 2, values of maximum width, proliferative zone thickness and condylar 294 In order to analyze proliferating index, captured JPEG files (1600×1200 pixels) were processed with Motic Image Plus 2.1 version 2.1.2 (Shimazu, Tokyo, Japan). Briefly, we selected arbitrary areas in proliferative and differentiated zones including more than 800 and 1,000 cells, in controls and experiments, respectively. PCNA-positive and negative nuclei, namely brownand blue-stained nuclei, were extracted spectrally and automatically counted. The percentage of positive cells divided by the sum of positive and negative cells was calculated as proliferating index (PI).
Statistical analyses
After calculating the Shapiro-Wilk-test for normality checking, the comparison of histomorphometric analysis data between controls and experiments was analyzed with Wilcoxon signedrank test. Multiple comparisons of values among four groups of controls and experiments were analyzed using the Kruskal-Wallis test followed by Steel-Dwass test. All statistical analyses were performed with R (The R Foundation for Statistical Computing, version 2.13.0). Simultaneously, p values less than 0.05 were considered statistically significant.
Results
Macroscopic findings
All animals of both controls and experiments showed neither mandibular malposition nor craniofacial malformations. The skin of the treated area demonstrated no dermal lesions such as dermatitis or ulcerative change.
Histological findings
One day after the final bFGF injection, control condyles were covered by fibrous tissue namely fibrous or articular zone composed of some collagen fibers and fibroblasts. Beneath the fibrous zone, a thin highly cellular area or proliferative zone of mesenchymal spindle cells was noted, followed by a maturation zone comprising flatten or oval chondrocytes embedded in hyaline matrix. Finally, large chondrocytes were distributed in the hypertrophic cell zone in the deepest area (Fig. 3a) . Experimental condyles showed neither traumatic changes nor morphological abnormalities in each layer. Fibrous to hypertrophic cell zones were clearly recognized without frank hyperplasia. However, fibrous to proliferative zones were markedly thicker than those of the control (Fig. 3b) .
Four days after the final injection, features of controls showed similar to that of the control at 1 day after the injection. The number of mesenchymal cells of proliferative zone and the thickness of the fibrous zone to hypertrophic cell zone somewhat decreased (Fig. 3c) . In experiments without any abnormal formations, the proliferative zone somewhat reduced its thickness comparing to that of the 1-day-experimental sample, while, chondrocytes and hypertrophic chondrocytes increased in number. Simultaneously, the distance of the condylar top to erosive zone and the maximum width of the experiment were greater than those of the control condyle (Fig. 3d) .
Seven days after the injection, controls showed that the distance from the fibrous zone to the front of endochondral ossification markedly decreased compared with that of the 4-day group (Fig. 3e) . Seven-day experiments showed that proliferative, maturation and hypertrophic cell zones were somewhat thicker than those of controls without any abnormal morphology. The front of ossification was moved toward the condylar top in contrast to the 4-day experiments, but this boundary was away from the top of the condyle compared with the controls (Fig. 3f ).
Fourteen days after the injection, both the controls and experiments showed similar morphological features, and significantly increased in width compared with the 7-day group. The thickness of fibrous to hypertrophic cell layers became somewhat thin, accompanied by the upward shift of ossification front and active formation of bone trabeculae (Fig. 3g, 3h ). This Figure 2 . Schematic illustration of morphometric analysis Line A and B are tangents parallel to the longitudinal axis of the condyle. Line C is the tangent to the top of condyle which is parallel to the line AB. To measure proliferative zone thickness and condylar height, a perpendicular line was drown from the contact point of line C. change was remarkable in the experiments (Fig. 3 3h) .
Immunohistochemical findings
PCNA-positive cells were mostly distributed in the proliferative zone but a few positive cells were also observed in the maturation zone in all groups. Positive cells of experimental groups were more than those of controls. Experimental groups tended to gradually increase in number from the 1-day group to the 7-day group. However, positive cells of the 14-day group seemed to decrease in number in comparison with the 7-day group (Fig. 4) .
Histomorphometric analysis
Morphometric data are summarized in Table 1 days, 7days and 14 days after the injection, respectively (Table  1) . Among experimental values, there were statistical differences except for the 4-day and 7-day groups, the 4-day and the 14-day groups and the7-day and 14-day groups (Fig. 5a ). proliferative zone thickness gradually increased and reached to a peak at 7 days after the injection and turned to decline, while experiments exhibited the maximum value at only 4 days after the injection. Experimental values were 1.32, 1.57, 1.29 and 1.09 fold larger than those of controls at 1 day, 4 days, 7days and 14 days after the injection, respectively (Table 1) . Multiple comparison tests revealed statistically significant differences among all experimental and control groups except for between the 4-day and 14-day controls (Fig. 5b) .
The trend of proliferative zone thickness ratio was similar to that of proliferative zone thickness. All experimental ratios were (Fig. 5c ).
Proliferating index analysis
Roughly 800 to 1,600 cells and 1,000 to 2,000 cells were observed within selected areas of controls and experiments, respectively. Mean values of proliferating index were significant differences between controls and experiments: 39.7±1% and 50.2±3% at 1 day, 43.2±1% and 68.9±4% at 4 days, 47.1±3% and 50.5±3% at 7 days, 43.0±3% and 50.4±2 at 14 days. Experimental values were 1.26, 1.59, 1.07 and 1.17 fold larger than those of Figure 5 . Box plots of maximum width (a), proliferative zone thickness (b), proliferative zone thickness ratio (c) and proliferative index (e). White and gray columns show controls and experiments, respectively. Width: maximum width of condyle, Thickness: proliferative zone thickness, Thickness ratio: proliferative zone thickness ratio, PI: proliferating index, G01C/E, G04C/E G07C/E and G14C/E: 1-day, 4-day, 7-day and 14-day groups of the controls and experiments. *p<0.05, **p<0.01, ***p<0.001, Kruskal-Wallis test with Steel-Dwass test 297 (Table 1) . Proliferating index of controls gradually increased and reached a peak at 7 days after the injection with a significant difference between each group, except for the 4-day group and the 14-day group, while the proliferating index value of the 4-day experiment was the highest one showing significant differences (p<0.001) comparing to values of other three experimental groups. There was no statistical difference between 1-day and 4-day, 1-day and 14-day, 7-day and 14-day experiments (Fig. 5d) .
Discussion
Minute investigations on the development of mandibular condyle have been reported but there are no bFGF application data on mandibular condyle of growing mice in vivo. Although insulin-like growth factor (IGF) is an important factor in condyle development 8) , it was reported that IGF local injection did not influence the 3-week-old rat of cartilage development 13) . In our study, it was suggested that total 0.3 μg administration of rhbFGF accelerated development of injected condyles, because all values calculated herein showed a statistically significant difference between experiments and controls. The dosage in our experiment was determined on the basis of the data reported by Shida et al.
who injected from 1 to 20 μg bFGF into the knee joint of 4-weekSprague-Dawley rats 12) . Their experiment showed that the joints injected with more than 5 μg of bFGF were larger than that in the control joints without bFGF injection and the effect of the injection was dose-dependent. Considering the weight of the 4-week-old Sprague-Dawley rats used in their experiment is about 50 g, an injection of 5 μg bFGF is equivalent to a 0.1 μg bFGF injection into a newborn mouse weighing 1 g.
Recombinant human bFGF works in low dose. The ED 50 of bFGF for the mitogenic activity in bovine aortic endothelial cell is 0.3 ng/ml in vitro 14) . An experimental study of corneal wound healing 15) showed that doses of 0.1 to 10 ng/ml bFGF were effective. However, the half-life of rhFGF is extremely short and is estimated at 0.9 minutes for T1/2alpha and 7 minutes for T1/ 2beta in mice after intravenous administration of 10 μg/kg 16) . Colin and his coworkers 17) reported that intravenously administrated bFGF was rapidly accumulated in almost all solid organs within 5 minutes and more than 65% of FGF was retained in liver. Twenty four hours after administration, native bFGF had totally disappeared in liver. In the investigation of pericardial administration, 19% of bFGF delivered in cardiac tissue was present at 150 minutes after administration 18) . Although there is no detailed data on pharmacokinetics of bFGF subcutaneous administration, it was reported that radiolabelled bFGF after a single injection were remained in the knee joint only several hours 12) . Considering these investigations, it seems that subcutaneously injected bFGF remains for more than 2 hours and is mostly cleared within 24 hours. The effect of a single injection of low dose bFGF was limited to condylar development. Therefore, we tried daily repetitive injections for three days in this examination. Although we have not the full answer to whether three time injections were appropriate, this investigation gave us interesting data as discussed below.
Histologically, control specimens showed that the thickness of mature and hyperplastic chondrocytes in the early stage (1 day and 4 days after injection) were thicker than those in the late stage (7 and 14 days after the injection). In other words, the erosive zone, which is the front of endochondral ossification, moved toward the top of the condyle. Morphometrically, both values of the thickness of proliferative zone and proliferating index reached their peaks at 7 days after the injection. Transition from active proliferation to thinning of mesenchymal cells and from thickening cartilage formation to active endochondral ossification is compatible with the normal development of mandibular condyle that has a capability for adaptive remodeling in response to external stimuli during or after natural growth 10, 19) . Usually, lactation, weaning and mastication periods are from birth to approximately 1 week, around 3 weeks and approximately 3 weeks onward after birth. Current data was analyzed from 3 days to 17 days after birth; therefore, histological and morphometric changes seemed to be caused by the transition from lactation period to weaning period 20, 21) . Morphometric analysis clearly showed that the thickness of proliferative zone was significantly different between the controls and the experiments. The proliferation tendency of experimental condyles reached its peak at 4 days and decreased with time course. At this stage, the experimental value of proliferative zone thickness was about 1.6 fold higher than that of the control. On the other hand, the proliferation tendency of control condyles reached a peak at 7 days after the injection. This difference could be caused by stimulation of mesenchymal proliferation by bFGF administration. In order to evaluate thickening of fibrous and proliferative zones against vertical growth, we analyzed the ratio of proliferative zone thickness and the height of the condyle. This data also showed a same tendency to the proliferative zone thickness. The peak of the proliferating index of the experiment was also at 4 days after the injection, whereas that of the control was at 7 days. The highest control-experiment ratio of proliferation index value was nearly 1.6 at 4 days similar to that of proliferative zone thickness at 4 days. As above mentioned, mesenchymal cell thickening and cell proliferation status are intimately related to each other. Basic FGF inhibits matrix production and increases cell proliferation resulting in clustering of cells in intervertebral discs 6) and the proliferation of mandibular condylar chondrocytes 21) . Zheng et al. reported that bFGF-transfected human mesenchymal cells derived from bone marrow cells had a highly proliferative ability 22) . Taken together with our data, it was thought that bFGF local injection resulted in mesenchymal cells proliferation, which was especially effective in the proliferative zone. However, its effect seems to be limited to less than a week.
As mentioned above, the half-life of rhFGF was extremely short 16) but the peak of cell proliferation reached at 4days after the final injection. This seems to be somewhat contradictory to the half-life of rhFGF. However, some growth factors synergistically act in cartilaginous development. Shi and his coworkers 23) demonstrated that bFGF increased both transcripts and proteins of bFGF and TGF-beta1 in vitro. They also showed that TGF beta1 significantly increased bFGF mRNA and production. The peak effect of bFGF production by TGF beta1 was at 4 days in contrast to at 12 hours by bFGF only. Thus synergic effects of growth factors after the final injection might prolong the acceleration of mesenchymal cell proliferation in vivo.
Interestingly, chondrocytes and hypertrophic chondrocytes of experiments increased in thickness at 4 and 7 days, and the distance from the condylar top to the edge of erosive zone of experiments was greater than that of controls. This feature may represent the delay of endochondral ossification. Administrated bFGF could possibly promote the differentiation of mesenchymal cells and pre-hypertrophic chondrocytes expressing collagen type II 24) , but this factor inhibits terminal differentiation of chondrocyte 25) and matrix components in the mandibular condyles 26) . The mechanism of chondrocyte differentiation via exogenous bFGF is unknown in our experimental model. Previous study showed that bFGF reduced runt-related transcription factor 2 (Runx2) 27) , which was closely related to upregulation of hypertrophic chondrocytespecific Col10A1 gene 28) . There is a possibility that chondrocyte maturation is inhibited through suppression of Runx2 function.
This might be the difference of the histological feature between the cartilaginous thicknesses of the control and experiment.
However, smad3 or TGF-beta1 signaling also represses terminal hypertrophic differentiation of chondrocyte, and these are essential for maintaining articular cartilage 29, 30) under the inhibition of TGFbeta signaling by negative regulator, such as an oncoprotein Ski 31) .
The alteration of growth factor gene expressions after bFGF injection should be investigated to clarify the regulation of chondrocyte differentiation.
In conclusion, additional experiments on dosage, administration interval and frequency are necessary in order to obtain further effects of condylar development. However, our experiment demonstrated that locally administrated bFGF could accelerate mesenchymal cell proliferation of mandibular condyle in the lactation period after birth. This model seems to be useful for clarifying bFGF function against cartilaginous differentiation, condyle development and endochondral ossification of mandibular condyle in vivo.
